176 related articles for article (PubMed ID: 33012340)
1. Overdue for an Overhaul: How Opioid Treatment Programs Can Learn From COVID-19.
Greenblatt AD; Magidson JF; Belcher AM; Gandhi D; Weintraub E
Mayo Clin Proc; 2020 Oct; 95(10):2076-2078. PubMed ID: 33012340
[No Abstract] [Full Text] [Related]
2. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
3. Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
Green TC; Bratberg J; Finnell DS
Subst Abus; 2020; 41(2):147-149. PubMed ID: 32314951
[TBL] [Abstract][Full Text] [Related]
4. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken.
Wakeman SE; Green TC; Rich J
Nat Med; 2020 Jun; 26(6):819-820. PubMed ID: 32555514
[TBL] [Abstract][Full Text] [Related]
5. Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective.
Mansuri Z; Shah B; Trivedi C; Beg U; Patel H; Jolly T
Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32628368
[No Abstract] [Full Text] [Related]
6. Preparing hospitals for coronavirus (COVID-19).
Jasper E
Hosp Pract (1995); 2020 Aug; 48(3):121-122. PubMed ID: 32306790
[No Abstract] [Full Text] [Related]
7. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
8. An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19.
Alexander GC; Stoller KB; Haffajee RL; Saloner B
Ann Intern Med; 2020 Jul; 173(1):57-58. PubMed ID: 32240283
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis-COVID 19 Infection: Treatment Options.
Tampouratzi E; Kanni T; Katsantonis J; Douvali T
Skinmed; 2020; 18(2):81-82. PubMed ID: 32501789
[No Abstract] [Full Text] [Related]
10. An Italian programme for COVID-19 infection in multiple sclerosis.
Sormani MP;
Lancet Neurol; 2020 Jun; 19(6):481-482. PubMed ID: 32359409
[No Abstract] [Full Text] [Related]
11. DMCN 2020 highlights: COVID-19 and beyond.
Dan B
Dev Med Child Neurol; 2020 Dec; 62(12):1345. PubMed ID: 33146436
[No Abstract] [Full Text] [Related]
12. Management of venous thromboembolism during the COVID-19 pandemic.
Skeik N; Mirza A; Manunga J
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):897-898. PubMed ID: 32454238
[No Abstract] [Full Text] [Related]
13. "Long covid": the Dutch response.
Burgers J
BMJ; 2020 Aug; 370():m3202. PubMed ID: 32816711
[No Abstract] [Full Text] [Related]
14. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis.
Becker WC; Fiellin DA
Ann Intern Med; 2020 Jul; 173(1):59-60. PubMed ID: 32240291
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 complications in children.
Baron M; Sherwen O; Heaton PA; Paul SP
Br J Nurs; 2020 Nov; 29(20):1146. PubMed ID: 33180606
[No Abstract] [Full Text] [Related]
16. From doctors as patients: a manifesto for tackling persisting symptoms of covid-19.
Alwan NA; Attree E; Blair JM; Bogaert D; Bowen MA; Boyle J; Bradman M; Briggs TA; Burns S; Campion D; Cushing K; Delaney B; Dixon C; Dolman GE; Dynan C; Frayling IM; Freeman-Romilly N; Hammond I; Judge J; Järte L; Lokugamage A; MacDermott N; MacKinnon M; Majithia V; Northridge T; Powell L; Rayner C; Read G; Sahu E; Shand C; Small A; Strachan C; Suett J; Sykes B; Taylor S; Thomas K; Thomson M; Wiltshire A; Woods V
BMJ; 2020 Sep; 370():m3565. PubMed ID: 32933949
[No Abstract] [Full Text] [Related]
17. The neurological impact of COVID-19.
The Lancet Neurology
Lancet Neurol; 2020 Jun; 19(6):471. PubMed ID: 32470408
[No Abstract] [Full Text] [Related]
18. Recommendations on cardiopulmonary resuscitation strategy and procedure for novel coronavirus pneumonia.
Song W; Liu Y; Ouyang Y; Chen W; Li M; Xianyu S; Yi S
Resuscitation; 2020 Jul; 152():52-55. PubMed ID: 32276002
[No Abstract] [Full Text] [Related]
19. Novel coronavirus and hospital infection prevention: Preparing for the impromptu speech.
Bearman G; Pryor R; Albert H; Brath L; Britton A; Cooper K; Doll M; Godbout EJ; Hemphill R; Stevens MP
Infect Control Hosp Epidemiol; 2020 May; 41(5):592-593. PubMed ID: 32122422
[No Abstract] [Full Text] [Related]
20. Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
Hoang P; Hurtubise B; Muppidi S
Neurology; 2020 Nov; 95(18):840-843. PubMed ID: 32817186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
